Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators
A Chinese patent for a COVID-19 vaccine filed just weeks after the virus emerged in the United States is drawing fresh scrutiny from U.S. investigators examining the origins of the pandemic and potential efforts to conceal early information about the virus …